Financial insights of DFPH

MyFinsight

For the quarter ending 2025-09-30, DFPH made $136,564,000 in revenue. -$16,504,000 in net income. Net profit margin of -12.09%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total operating revenue	136,564,000	119,802,000	104,406,000	97,837,000
Direct costs-Health Care Patient Service	54,572,000	51,150,000	-	-
Direct costs-Dispensary Revenue	63,072,000	51,086,000	-	-
Direct costs	-	-	87,157,000	84,735,333.333
Direct costs-Clinical Research Trials And Other Revenue	0	65,000	-	-
Selling, general and administrative expense	25,251,000	26,907,000	25,376,000	27,060,666.667
Depreciation and amortization	1,723,000	1,805,000	1,784,000	1,571,333.333
Total operating expenses	144,618,000	131,013,000	114,317,000	113,258,666.667
Loss from operations	-8,054,000	-11,211,000	-9,911,000	-15,421,666.667
Interest expense, net	1,920,000	1,870,000	5,570,000	1,757,000
Change in fair value of derivative warrant liabilities	150,000	53,000	43,000	-199,666.667
Change in fair value of conversion option derivative liabilities	-5,977,000	-3,987,000	-3,309,000	899,000
Other, net	-403,000	-19,000	-752,000	-103,333.333
Total other non-operating loss	-8,450,000	-5,929,000	-9,674,000	-761,666.667
Loss before provision for income taxes	-16,504,000	-17,140,000	-19,585,000	-16,183,333.333
Income tax benefit	0	-131,000	-	0
Net loss	-16,504,000	-17,009,000	-19,585,000	-16,183,333.333

Basic (in dollars per share)	-0.14	-0.15	-0.21	-0.177
Basic (in shares)	97,474,797	93,203,665	77,098,825	-160,381.667
Diluted (in dollars per share)	-0.14	-0.15	-0.21	-0.177
Diluted (in shares)	97,474,797	93,203,665	77,098,825	-160,381.667